हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Serum Institute of India (SII)
Serum Institute of India (SII) News
COVID-19
23 Nov 2021
Serum Institute of India to start Covishield supply to COVAX countries
"The first consignment from the Pune facility of Serum Institute of India was scheduled to leave for Nepal today. However, due to some reason, it has been delayed by two to three days," said SII sources.
COVID-19
14 Aug 2021
SII chairman Cyrus Poonawalla warns against mixing of vaccine, here’s why
"I am against the mixing of two different vaccines. There is no need to mix two different vaccines," said Cyrus Poonawalla. He further stated that the efficacy of this approach has not been proven in field trials involving thousands of participants.
Covovax
06 Aug 2021
Hope to launch Covovax vaccine for adults in October this year: SII CEO
Poonawala said he is hopeful that for adults Covovax will be launched in October, depending on DCGI approvals. It will be a two-dose vaccine and the price will be decided at the time of launch, he added. Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes.
COVID-19 vaccine
18 Jul 2021
Good news: SII CEO Poonawalla as 16 European countries recognise Covishield
On Saturday, France lifted travel restrictions for fully vaccinated travellers. Indian government has been pushing European Union member countries to recognise both Covishield and Covaxin in order to ease travel for the people
COVID-19 vaccine
17 Jul 2021
No application received for EU authorisation of Covishield: EMA
EMA has approved only four vaccines namely, Comirnaty of Pfizer/BioNTech, Moderna's Spikevax, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson's Janssen. The SII’s CEO Adar Poonawalla had earlier said that the company is confident of receiving approval from the EMA.
COVID-19 vaccine
28 Jun 2021
Serum Institute CEO Adar Poonawalla assures help to Indians for this reason
The CEO of Serum Institute of India (SII) Adar Poonawalla on Monday assured the people of the nation that the issue is being with at the highest level. The statement comes amid the reports of the European Union’s new concept of Green Pass is doing rounds in media.
COVID-19 vaccine
18 Jun 2021
SII to launch second COVID-19 vaccine Covavax by September: Report
Serum Institute plans to start clinical trials of the Novavax shot for children in July. ANI reported. "This vaccine is very safe and highly effective. It`ll be produced in India," Centre said about Covavax.
COVID-19 vaccine
31 May 2021
India aims to procure 20-25 crore COVID-19 vaccine by July end: Report
The Centre on Sunday (May 30, 2021) said that it targets to procure 20-25 crore coronavirus vaccine doses by July-end, and 30 crore doses in August-September. The SII officials in a recent letter addressed to Home Minister Amit Shah said that their employees have been working round the clock in spite of the challenges that the pandemic presents.
COVID-19
22 May 2021
Centre widened COVID vaccination drive without considering stock: SII
The executive director of SII, Suresh Jadhav on Friday alleged that the central government widened the COVID-19 vaccination drive without into account the available stock of vaccines. "India should have followed the WHO guidelines and prioritised vaccination accordingly," said Suresh Jadhav.
Adar Poonawalla
18 May 2021
It would take 2-3 years for entire world population to get fully vaccinated
Poonawalla said that it will take another two to three years for the entire world population to get fully vaccinated He also said that "a vaccination drive for such a large population cannot be completed within 2-3 months" The serum has delivered more than 200 million doses
Adar Poonawalla
18 May 2021
Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 crore
As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share.
Coronavirus
14 May 2021
Hyderabad based Bharat Biotech to start producing coronavirus vaccines in Pune
Bharat Biotech International Ltd will soon start manufacturing Covid-19 vaccines in Pune The state would also request the BBIL to give priority to supply vaccines to Maharashtra after fulfilling its commitments to the Centre Currently, the government-owned BBIL is one of the two Indian companies manufacturing the Covaxin and Covishield vaccines
Bill Gates
30 Apr 2021
Bill Gates says COVID vaccine formula should not be shared with India
Bill Gates in an interview with Sky News was asked if it would be possible to change the intellectual property law Bill Gates refused to share vaccine formula Bill Gates faces heat from global community for this statement
Coronavirus
25 Mar 2021
India delays big exports of AstraZeneca vaccine as Covid-19 cases surge
COVAX has so far received 17.7 million AstraZeneca doses from the SII The SII has already delayed shipments of the AstraZeneca drug to Brazil, Britain, Morocco and Saudi Arabia With 11.7 million cases, India has reported the highest number of coronavirus infections after the United States and Brazil
COVISHIELD
22 Mar 2021
Centre asks states, UTs to increase gap between two doses of Covishield
The Centre also clarified that the above instruction is only for Covishield and not Bharat Biotech’s Covaxin. "This decision of revised time interval between two doses is applicable ONLY to COVISHIELD and NOT to COVAXIN Vaccine," the government stated.
Nepal COVID-19 vaccine
21 Feb 2021
COVID-19: Nepal to begin inoculation drive as it receives Indian vaccines
Nepal has expedited preparations to start inoculating elderly and most vulnerable age groups from next month as it received a batch of COVID-19 vaccines purchased from India. A batch of one million Covishield vaccines developed by the Serum Institute of India (SII) was delivered on Sunday (February 21) via an Air India flight.
Coronavirus
03 Aug 2020
DCGI nod to SII for phase 2 and 3 human clinical trials of COVID-19 vaccine
The approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa. The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for COVID-19 had submitted its first application to the DCGI on July 25.
1124765
1
0
Loading...
Trending news
DNA Video
DNA: Ban on Muslims in Tirupati Temple?
DNA Video
DNA: Violence 2.0 in Bangladesh!
DNA Video
DNA: Ruckus over Lord Ram in JNU!
DNA Video
DNA: 'Inflation bomb' exploded on Diwali
Gangster Lawrence Bishnoi
DNA: Lawrence Bishnoi Under Threat?
DNA Video
DNA: Lawrence also threatens Abhinav Arora!
DNA Video
DNA: Double standards of Bollywood stars on Hindu Festivals!
Mumbai Muslims Riots
DNA: Ruckus ober Firecrackers in Mumbai!
DNA Video
DNA: Sharia law in Bangladesh!
Lawrence Bishnoi Special 26 Selfie
DNA: Crime Files of Lawrence Gang!
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK